| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alternative business models for drug discovery
|
Bunin, Barry A.
|
|
2011
|
16 |
15-16 |
p. 643-645
3 p.
|
article
|
| 2 |
Animal models of asthma: value, limitations and opportunities for alternative approaches
|
Holmes, Anthony M.
|
|
2011
|
16 |
15-16 |
p. 659-670
12 p.
|
article
|
| 3 |
A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #2: protocol optimization and best practices
|
Schwarz, Adam J.
|
|
2011
|
16 |
15-16 |
p. 671-682
12 p.
|
article
|
| 4 |
Biopharma business models in Canada
|
March-Chordà, I.
|
|
2011
|
16 |
15-16 |
p. 654-658
5 p.
|
article
|
| 5 |
Contents page 2
|
|
|
2011
|
16 |
15-16 |
p. iii-
1 p.
|
article
|
| 6 |
Contents page 1
|
|
|
2011
|
16 |
15-16 |
p. i-
1 p.
|
article
|
| 7 |
DNA demethylases: a new epigenetic frontier in drug discovery
|
Carey, Nessa
|
|
2011
|
16 |
15-16 |
p. 683-690
8 p.
|
article
|
| 8 |
Erratum to: Heparin/heparan sulphate-based drugs
|
Gandhi, Neha S.
|
|
2011
|
16 |
15-16 |
p. 741-
1 p.
|
article
|
| 9 |
FDA-approved drug labeling for the study of drug-induced liver injury
|
Chen, Minjun
|
|
2011
|
16 |
15-16 |
p. 697-703
7 p.
|
article
|
| 10 |
Follow-on drugs: How far should chemists look?
|
Giordanetto, Fabrizio
|
|
2011
|
16 |
15-16 |
p. 722-732
11 p.
|
article
|
| 11 |
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery – the GSK experience
|
Vanderwall, Dana E.
|
|
2011
|
16 |
15-16 |
p. 646-653
8 p.
|
article
|
| 12 |
mTOR as a multifunctional therapeutic target in HIV infection
|
Nicoletti, Ferdinando
|
|
2011
|
16 |
15-16 |
p. 715-721
7 p.
|
article
|
| 13 |
Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
|
Kell, Douglas B.
|
|
2011
|
16 |
15-16 |
p. 704-714
11 p.
|
article
|
| 14 |
Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat
|
Torabi-Rahvar, Monireh
|
|
2011
|
16 |
15-16 |
p. 733-740
8 p.
|
article
|
| 15 |
ROCK: the Roche medicinal chemistry knowledge application – design, use and impact
|
Mayweg, Alexander
|
|
2011
|
16 |
15-16 |
p. 691-696
6 p.
|
article
|
| 16 |
The solution-phase design and synthesis of libraries for the discovery of CNS active substances
|
Edwards, Paul John
|
|
2011
|
16 |
15-16 |
p. 742-744
3 p.
|
article
|
Journal description